CJC/IPA Blend combines a GHRH analog such as CJC-1295 with Ipamorelin, a ghrelin-receptor agonist. The blend is meant to bring together two different upstream pathways involved in endogenous growth-hormone signaling. It is described as a research blend used in endocrine signaling studies.
Top Selling CJC/IPA Blend Compounds Products
Frequently Asked Questions
Explore answers about research peptides, applicable Certificates of Analysis, ordering, and shipping. All products are supplied for laboratory research use only.
This blend is usually studied for pulsatile growth-hormone release, GH/IGF-1 signaling, and experimental models of endocrine signaling. The exact behavior of the blend depends on whether the CJC component is DAC or non-DAC, since that changes its half-life and pulse pattern.